A recent publication in the International Journal of Cardiology, “Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis” has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death. Co-authored by Dr. James Jenkins, a cardiologist at Ochsner Health, the study analyzed data from multiple clinical trials to assess the therapeutic and clinical impact of PADN in PH patients.
Leave A Comment